Instrument 8: Learning Session Day 1 Evaluation
A Breakthrough Series Collaborative for
 
	The purpose of the information
	collection is to get feedback on improvement team members’
	experiences with Day 1 of a learning session. In-person Learning
	sessions will take place twice over the course of the project. The
	Day 1 Evaluation collects information on what was most and least
	helpful, the questions participants have, and any other concerns
	that participants want to discuss. The Fathers and Continuous
	Learning (FCL) team will use the information to improve the second
	day of the learning session and to understand participants’
	reactions to the process. 
	 
	It will be used both to plan learning
	sessions and to understand the successes and challenges of
	implementation for pilot study. 
	 
	Public reporting burden for this
	collection of information is estimated to average 10 minutes per
	response. Providing this information is voluntary, and all responses
	that are collected will be kept private to the extent permitted by
	law. 
	 
	An agency may not conduct or sponsor,
	and a person is not required to respond to, a collection of
	information unless it displays a currently valid OMB control number.
	The OMB number for this information collection is 0970-0531
	and the expiration date is 07/31/2022. 
	
	
Day 1 Evaluation
This evaluation is intended to help us assess how well today (Day 1 of the learning session) met project goals and your expectations. Responses will be kept anonymous and used for planning purposes only, so please be candid! We will use your responses to reshape tomorrow’s agenda as needed.
1. What was most helpful today?
2. What was least helpful today?
3. What do you hope we will cover, explain, or talk about tomorrow?
4. Do you have any general feedback or suggestions for this learning session or the BSC overall?
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document | 
| Author | Cleo Jacobs Johnson | 
| File Modified | 0000-00-00 | 
| File Created | 2022-01-17 |